Research Article

The Prevalence of Single and Multiple Thyroid Nodules and Its Association with Metabolic Diseases in Chinese: A Cross-Sectional Study

Table 2

Association between metabolic diseases and thyroid nodules analyzed by univariable logistic regression (N = 9146).

TotalMaleFemale
TN (N, %)NTN (N, %)OR (95% CI) valueTN (N, %)NTN (N, %)OR (95% CI) valueTN (N, %)NTN (N, %)OR (95% CI) value

BMI (kg/m2)
 18.5–23.91111 (33.0)2253 (67.0)1.0 (ref)1.0433 (24.8)1316 (75.2)1.0 (ref)1.0937 (58.0)678 (42.0)1.0 (ref)1.0
 24.0–27.91310 (32.7)2702 (67.3)0.98 (0.89–1.08)0.73811 (27.3)2161 (72.7)1.14 (1.00–1.31)0.06541 (52.0)499 (48.0)1.28 (1.09–1.49)<0.01
 ≥28540 (30.5)1230 (69.5)0.89 (0.79–1.01)0.07349 (25.0)1049 (75.0)1.01 (0.86–1.19)0.89181 (48.7)191 (51.3)1.46 (1.16–1.83)<0.01
Hypertension
 No2151 (32.2)4530 (67.8)1.0 (ref)1.01100 (25.9)3155 (74.1)1.0 (ref)1.01051 (43.3)1375 (56.7)1.0 (ref)1.0
 Yes810 (32.9)1655 (67.1)0.97 (0.88–1.07)0.55493 (26.4)1371 (73.6)1.03 (0.91–1.17)0.63317 (52.7)284 (47.3)1.46 (1.22–1.75)<0.01
Central obesity (cm)
 Male <90; female <851679 (31.9)3586 (68.1)1.0 (ref)1.0766 (24.5)2359 (75.5)1.0 (ref)1.0913 (42.7)1227 (57.3)1.0 (ref)1.0
 Male ≥90; female ≥851282 (33.0)2599 (67.0)1.05 (0.96–1.15)0.25827 (27.6)2167 (72.4)1.18 (1.05–1.32)0.01455 (51.3)432 (48.7)1.42 (1.21–1.66)<0.01
High TG
 <1.731761 (34.2)3395 (65.8)1.0 (ref)1.0757 (26.4)2111 (73.6)1.0 (ref)1.01004 (43.9)1284 (56.1)1.0 (ref)1.0
 ≥1.731200 (30.1)2790 (69.9)0.83 (0.76–0.91)<0.01836 (25.7)2415 (74.3)0.97 (0.86–1.08)0.55364 (49.3)375 (50.7)1.24 (1.05–1.47)0.01
High TC (mmol/L)
 <5.72185 (32.1)4624 (67.9)1.0 (ref)1.01178 (26.2)3321 (73.8)1.0 (ref)1.01007 (43.6)1303 (56.4)1.0 (ref)1.0
 ≥5.7776 (33.2)1561 (66.8)1.05 (0.95–1.16)0.32415 (25.6)1205 (74.4)0.97 (0.85–1.11)0.66361 (50.3)356 (49.7)1.31 (1.11–1.55)<0.01
Low HDL-C
 ≥0.92815 (32.5)5834 (67.5)1.0 (ref)1.01471 (26.0)4196 (74.0)1.0 (ref)1.01344 (45.1)1638 (54.9)1.0 (ref)1.0
 <0.9146 (29.4)351 (70.6)0.86 (0.71–1.05)0.14122 (27.0)330 (73.0)1.06 (0.85–1.31)0.6324 (53.3)21 (46.7)1.39 (0.77–2.51)0.27
High LDL-C
 <3.12543 (32.2)5353 (67.8)1.0 (ref)1.01358 (26.0)3873 (74.0)1.0 (ref)1.01185 (44.5)1480 (55.5)1.0 (ref)1.0
 ≥3.1418 (33.4)832 (66.6)1.06 (0.93–1.20)0.39235 (26.5)653 (73.5)1.03 (0.87–1.21)0.75183 (50.6)179 (49.4)1.28 (1.03–1.59)0.03
DM (mmol/L)
 Normal1567 (30.1)3638 (69.9)1.0 (ref)1.0787 (23.5)2557 (76.5)1.0 (ref)1.0780 (41.9)1081 (58.1)1.0 (ref)1.0
 IGR852 (33.7)1674 (66.3)1.18 (1.07–1.31)<0.01467 (26.9)1268 (73.1)1.20 (1.05–1.37)0.01385 (48.7)406 (51.3)1.31 (1.11–1.55)<0.01
 DM542 (38.3)873 (61.7)1.44 (1.28–1.63)<0.01339 (32.6)701 (67.4)1.57 (1.35–1.83)<0.01203 (54.1)172 (45.9)1.64 (1.31–2.04)<0.01
HUA (μmol/L)
 Male ≤420; female ≤3502133 (33.6)4223 (66.4)1.0 (ref)1.01012 (26.6)2798 (73.4)1.0 (ref)1.01121 (44.0)1425 (56.0)1.0 (ref)1.0
 Male >420; female >350828 (29.7)1962 (70.3)0.84 (0.76–0.92)<0.01581 (25.2)1728 (74.8)0.93 (0.83–1.05)0.23247 (51.4)234 (48.6)1.34 (1.10–1.63)<0.01
MS
 No1949 (32.3)4092 (67.7)1.0 (ref)1.0896 (25.0)2689 (75.0)1.0 (ref)1.01053 (42.9)1403 (57.1)1.0 (ref)1.0
 Yes1012 (32.6)2093 (67.4)1.02 (0.93–1.11)0.76697 (27.5)1837 (72.5)1.14 (1.02–1.28)0.03315 (55.2)256 (44.8)1.64 (1.37–1.97)<0.01
Fatty liver
 No1838 (32.9)3746 (67.1)1.0 (ref)1.0807 (25.4)2371 (74.6)1.0 (ref)1.01031 (42.9)1375 (57.1)1.0 (ref)1.0
 Yes1123 (31.5)2439 (68.5)0.94 (0.86–1.03)0.17786 (26.7)2155 (73.3)1.07 (0.96–1.20)0.24337 (54.3)284 (45.7)1.58 (1.33–1.89)<0.01

Note: TN: thyroid nodules; BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; IGR: sugar adjustment; DM: diabetes mellitus; HUA: hyperuricemia; MS: metabolic syndrome.